Skip to main content
Log in

Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease

  • Original Ppaer
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospitalisation) and laboratory parameters (euglobulin clot lysis time, haematocrit, platelet count, and leucocyte count) of 25 consecutive patients with avascular necrosis of the femoral head from sickle cell disease were compared with those of 26 age- and sex-matched sickle cell disease patients without avascular necrosis. The group with avascular necrosis of the femoral head (mean age 23.7±4.9 years) had a significantly higher rate of painful crises (p = 0.03) and hospitalisations per year (p = 0.002) than the group without avascular necrosis (mean age 21.6±5.2 years). The group with avascular necrosis also had a significantly higher euglobulin clot lysis time than the group without avascular necrosis (p = 0.001). In conclusion, it appears that not all patients with sickle cell disease have impaired fibrinolytic activity. The aetiology of avascular necrosis in sickle cell disease is multifactorial.

Résumé

Les mécanismes de la nécrose de la tête fémorale dans la drépanocytose sont encore relativement obscures. Le but de cette étude est de mettre en évidence les facteurs de risque de la tête fémorale chez les patients présentant une drépanocytose. Matériel et méthode : l’évaluation des paramètres cliniques (fréquence des crises, nombre d’hospitalisations) et biologique (lyse du caillot, euglobuline, hématrocrite, plaquettes et numération leucocytaire) de 25 patients consécutifs présentant une nécrose avasculaire de la tête fémorale dans le cadre d’une drépanocytose ont été comparés aux données d’une série de patients âgés en moyenne de 26 ans et présentant une drépanocytose sans nécrose aseptique. Résultats : le groupe des nécroses aseptiques de tête fémorale était âgé en moyenne de 23,7 ± 4,9 avec un nombre de crises douloureuses significativement plus élevé (p = 0,03) et un nombre d’hospitalisation également plus élevé (p = 0,002) que dans le groupe des nécroses avasculaires simples, moyenne d’âge 21,6 ± 5,2 ans. Le groupe présentant une nécrose avasculaire présentant également un taux de lyse du caillot et d’euglobuline plus élevé que dans le groupe sans nécrose (p = 0,001). Conclusion : il semble que les patients porteurs d’une drépanocytose comportent sur le plan biologique une activité fribrinolytique plus importante. L’étiologie de la nécrose avasculaire dans le cadre de la drépanocytose est multifactorielle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adekile AD, Gupta R, Yacoub F, Sinan T, Al-Bloushi M, Haider MZ (2001) Avascular necrosis of the hip in children with sickle cell disease and the high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait. Acta Haematol 105(1):27–31

    Article  PubMed  CAS  Google Scholar 

  2. Akinyoola AL, Adediran IA, Asaleye CM (2007) Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J 14(3):217–220

    PubMed  CAS  Google Scholar 

  3. Aluoch JR (1998) Fibrinolytic activity in adult Kenyan patients with sickle cell disease. East Afr Med J 75(6):351–352

    PubMed  CAS  Google Scholar 

  4. Bain BJ (1995) Basic haematological techniques. In: Dacie JV, Lewis SM (eds) Practical haematology, 8th edn. Churchill Livingstone, London, pp 37–66

    Google Scholar 

  5. Bayazit AK, Kilinc Y (2001) Natural coagulation inhibitors (protein C, Protein S, antithrombin) in patients with sickle cell anemia in a steady state. Pediatr Int 43(6):592–596

    Article  PubMed  CAS  Google Scholar 

  6. Busari FI, Shokunbi WA, Jeremiah ZA (2007) Plasma fibrinogen levels in Nigerian homozygous (Hb SS) sickle cell patients. Hemoglobin 31(1):89–92

    Article  CAS  Google Scholar 

  7. Dacie JV, Lewis SM (1995) Preparation and staining methods for blood and bone marrow film. In: Dacie JV, Lewis SM (eds) Practical haematology, 8th edn. Churchill Livingstone, London, pp 75–85

    Google Scholar 

  8. Famodu AA (1988) Plasma fibrinolytic activity in sickle cell disease. Trop Geogr Med 40(4):331–333

    PubMed  CAS  Google Scholar 

  9. Hawker H, Neilson H, Hayes RJ, Serjeant GR (1982) Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease. Br J Haematol 50(1):29–34

    Article  PubMed  CAS  Google Scholar 

  10. Hernigou P, Habibi A, Bachir D, Galacteros F (2006) The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. Bone Joint Surg Am 88(12):2565–2572

    Article  Google Scholar 

  11. Iwegbu CG, Fleming AF (1985) Avascular necrosis of the femoral head in sickle cell disease. A series from the Guinea savannah of Nigeria. J Bone Joint Surg (Br) 67(1):29–3

    CAS  Google Scholar 

  12. Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ (2003) Procoagulants and osteonecrosis. J Rheumatol 30(4):783–791

    PubMed  CAS  Google Scholar 

  13. Koo KH, Song HR, Ha YC, Kim JR, Kim SJ, Kim KI, Chang KC, Ahn IO, Cho SH (2002) Role of thrombotic and fibrinolytic disorders in the etiology of Perthes’ disease. Clin Orthop Relat Res 399:162–167

    Article  PubMed  Google Scholar 

  14. Kurantsin-Mills J, Ofosu FA, Safa TK, Siegel RS, Lessin LS (1992) Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol 81(4):539–544

    Article  PubMed  CAS  Google Scholar 

  15. Lee JS, Koo KH, Ha YC, Koh KK, Kim SJ, Kim JR, Song HR, Cho SH (2003) Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Orthop Relat Res 417:270–276

    PubMed  Google Scholar 

  16. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH et al (1991) Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 325(21):1476–1481

    PubMed  CAS  Google Scholar 

  17. Mukisi-Mukaza M, Elbaz A, Samuel-Leborgne Y, Keclad L, Le Turdu-Chicot C, Christophe-Duchange E, Merault G (2000) Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease. Orthopedics 23(4):357–363

    PubMed  CAS  Google Scholar 

  18. Nsiri B, Gritli N, Bayoudh F, Messaoud T, Fattoum S, Machghoul S (1996) Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease. Hematol Cell Ther 38(3):279–284

    Article  PubMed  CAS  Google Scholar 

  19. Posan E, Szepesi K, Gaspar L, Csernatony Z, Harsfalvi J, Ajzner E, Toth A, Udvardy M (2003) Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis 14(3):243–248

    Article  PubMed  CAS  Google Scholar 

  20. Urano T, Sakakibara K, Rydzewski A, Urano S, Takada Y, Takada A (1990) Relationship between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Thromb Haemost 63(1):82–86

    PubMed  CAS  Google Scholar 

  21. Von Kaulla KN (1963) Chemistry of thrombosis. Human fibrinolytic system. Charles C Thomas, Illinois, pp 49–60

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. L. Akinyoola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akinyoola, A.L., Adediran, I.A., Asaleye, C.M. et al. Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease. International Orthopaedics (SICOT) 33, 923–926 (2009). https://doi.org/10.1007/s00264-008-0584-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-008-0584-1

Keywords

Navigation